Access cutting-edge convergence insufficiency treatment through this clinical trial at a research site in Downers Grove. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Downers Grove location
Preparing your pre-screening questions…
Access convergence insufficiency specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related convergence insufficiency treatment provided free
Check if you qualify for this convergence insufficiency clinical trial in Downers Grove, IL
No-Cost Study Care
Local to Downers Grove
Convenient for IL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this randomized controlled trial is to test the effectiveness of non-invasive brain stimulation in treating adults with symptomatic convergence insufficiency compared to vergence/accommodative therapy. The main questions it aims to answer are: 1. Can non-invasive brain stimulation shorten the treatment time of office-based vergence/accommodative therapy for convergence insufficiency? 2. Is non-invasive brain stimulation alone just as effective as office-based vergence/accommodative therapy in treating convergence insufficiency? The investigators hypothesize that non-invasive brain stimulation will shorten the treatment time from 12 weeks to 8 weeks of office-based vergence/accommodative therapy and that non-invasive brain stimulation alone would be equally effective as office-based vergence/accommodative therapy in improving symptomatic convergence insufficiency. Participants will be randomized into one of three treatment groups: 1. Non-invasive brain stimulation with office-based vergence/accommodative therapy. 2. Sham stimulation with office-based vergence/accommodative therapy. 3. Non-invasive brain stimulation only. Researchers will compare baseline measurements of near point of convergence (NPC) and positive fusional vergence (PFV) to post-treatment measurements for each group.
Sponsor: Midwestern University
Yes, this clinical trial (NCT05877560) has an active research site in Downers Grove, IL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for convergence insufficiency treatment options in Downers Grove, IL, this clinical trial (NCT05877560) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Downers Grove research site is actively enrolling participants for this clinical trial. You'll receive care from experienced convergence insufficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all convergence insufficiency clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in Downers Grove — not just this study.
Browse Interstitial Cystitis Trials in Downers Grove →